Table 1. Randomized trials comparing... | American Society of Hematology

Table 1.

Randomized trials comparing allogeneic peripheral blood to bone marrow.

		ANC^a		PLT^b		TRM		aGVHD		cGVHD		Overall Survival
Study	n	PB	BM	PB	BM	PB, %	BM, %	PB, %	BM, %	PB, %	BM, %	PB, %	BM, %
^a Engraftment (days) ANC > 500/mm³
^b Engraftment (days) Plt > 25000/mm³
Abbreviations: ANC, absolute neutrophil count; PLT, platelets; TRM, treatment-related mortality; aGVHD, acute graft-versus-host disease; cGVHD, chronic GVHD; PB, peripheral blood; BM, bone marrow.
Vigorito³²	37	16	18	12	17	78	63	27	19	100	50	47	51
Blaise³³	101	15	21	13	21	23	21	44	42	50	28	61	61
Powles³⁴	39	17.5	23	11	18	31	35	68	58	44	40	70	68
Heldal³⁵	61	17	23	13	21	17	10	21	10	56	27	80	73
Schmitz³⁶	350	12	15	15	20	ND	ND	52	39	74	53	ND	ND
Couban³⁷	228	19	22	16	22	7.5	16	40	40	71	55	68	55
Bensinger³⁸	172	16	21	13	19	21	30	64	57	46	35	66	54

		ANC^a		PLT^b		TRM		aGVHD		cGVHD		Overall Survival
Study	n	PB	BM	PB	BM	PB, %	BM, %	PB, %	BM, %	PB, %	BM, %	PB, %	BM, %
^a Engraftment (days) ANC > 500/mm³
^b Engraftment (days) Plt > 25000/mm³
Abbreviations: ANC, absolute neutrophil count; PLT, platelets; TRM, treatment-related mortality; aGVHD, acute graft-versus-host disease; cGVHD, chronic GVHD; PB, peripheral blood; BM, bone marrow.
Vigorito³²	37	16	18	12	17	78	63	27	19	100	50	47	51
Blaise³³	101	15	21	13	21	23	21	44	42	50	28	61	61
Powles³⁴	39	17.5	23	11	18	31	35	68	58	44	40	70	68
Heldal³⁵	61	17	23	13	21	17	10	21	10	56	27	80	73
Schmitz³⁶	350	12	15	15	20	ND	ND	52	39	74	53	ND	ND
Couban³⁷	228	19	22	16	22	7.5	16	40	40	71	55	68	55
Bensinger³⁸	172	16	21	13	19	21	30	64	57	46	35	66	54